New Hope for Malaria Vaccine
In Context The Malaria vaccine named RTS,S/AS01 (Mosquirix) has modest efficacy and reduces severe Malaria cases by only about 30 per cent after four doses given to children under age 5. It still provides significant public health benefits, and could save thousands of lives every year. About the vaccines RTS,S/AS01 was developed by GlaxoSmithKline for […]